{PDOC50084} {PS50084; KH_TYPE_1} {PS50823; KH_TYPE_2} {BEGIN} ********************** * KH domain profiles * ********************** The K homology (KH) domain was first identified in the human heterogeneous nuclear ribonucleoprotein (hnRNP) K. It is a domain of around 70 amino acids that is present in a wide variety of quite diverse nucleic acid-binding proteins [1]. It has been shown to bind RNA [2,3]. Like many other RNA-binding motifs, KH motifs are found in one or multiple copies (14 copies in chicken vigilin) and, at least for hnRNP K (three copies) and FMR-1 (two copies), each motif is necessary for in vitro RNA binding activity, suggesting that they may function cooperatively or, in the case of single KH motif proteins (for example, Mer1p), independently [1]. According to structural [2,3,4] analysis the KH domain can be separated in two groups. The first group or type-1 contain a beta-alpha-alpha-beta-beta-alpha structure, whereas in the type-2 the two last beta-sheet are located in the N terminal part of the domain (alpha-beta-beta-alpha-alpha-beta). Sequence similarity between these two folds are limited to a short region (VIGXXGXXI) in the RNA binding motif. This motif is located between helice 1 and 2 in type-1 and between helice 2 and 3 in type-2. Some proteins known to contain a type-1 KH domain are listed below: - Bacterial polyribonucleotide nucleotidyltransferases (EC 2.7.7.8). - Vertebrate fragile X mental retardation protein 1 (FMR1). Associated to polysomes and might be involved in the transport of mRNA from the nucleus to the cytoplasm. - Eukaryotic heterogeneous nuclear ribonucleoprotein K (hnRNP K), one of at least 20 major proteins that are part of hnRNP particles in mammalian cells. It is presumed to be involved in transport and/or processing of heterogeneous nuclear and mature RNA. - Mammalian poly(rC) binding proteins. - Artemia salina glycine-rich protein GRP33. - Yeast PAB1-binding protein 2 (PBP2). - Vertebrate vigilin. An oestrogen-inducible protein in polysome extracts which binds specifically to a segment of the 3'untranslated region (UTR) of estrogen-stabilized vitellogenin mRNA. - Human high-density lipoprotein binding protein (HDL-binding protein). - Human onconeural ventral antigen-1 (NOVA-1). May regulate RNA splicing or metabolism in a specific subset of developing neurons. Proteins known to contain a type-2 KH domain are listed below: - Eukaryotic and prokaryotic S3 family of ribosomal proteins. - Prokaryotic GTP-binding protein era. To identify KH domains we developed two profiles, one specific for type-1 and the other type-2. Both profiles cover the whole domain. -Sequences known to belong to this class detected by the first profile: ALL. -Other sequence(s) detected in Swiss-Prot: also detects six KH type-2 domains. -Sequences known to belong to this class detected by the second profile: ALL. -Other sequence(s) detected in Swiss-Prot: NONE. -Last update: December 2001 / First entry. [ 1] Burd C.G., Dreyfuss G. "Conserved structures and diversity of functions of RNA-binding proteins." Science 265:615-621(1994). PubMed=8036511 [ 2] Musco G., Kharrat A., Stier G., Fraternali F., Gibson T.J., Nilges M., Pastore A. "The solution structure of the first KH domain of FMR1, the protein responsible for the fragile X syndrome." Nat. Struct. Biol. 4:712-716(1997). PubMed=9302998 [ 3] Baber J.L., Libutti D., Levens D., Tjandra N. "High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor." J. Mol. Biol. 289:949-962(1999). PubMed=10369774; DOI=10.1006/jmbi.1999.2818 [ 4] Grishin N.V. "KH domain: one motif, two folds." Nucleic Acids Res. 29:638-643(2001). PubMed=11160884 -------------------------------------------------------------------------------- PROSITE is copyrighted by the SIB Swiss Institute of Bioinformatics and distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0) License, see https://prosite.expasy.org/prosite_license.html -------------------------------------------------------------------------------- {END}